Trademark: FERRY 2172510
Word
FERRY
ID
2172510
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
21 April 2021
Registration Date
21 April 2021
Renewal Date
21 April 2031
Owner(s)
Service
King & Wood Mallesons
Goods and Services:
Class 42:
Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; conducting post-authorization research for evaluating epidemiological results; Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; conducting post-authorization research and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders
Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; conducting post-authorization research for evaluating epidemiological results; Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; conducting post-authorization research and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders
Class 44:
Providing medical information; providing research information to patients and practitioners as to the results of clinical trials; providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders; providing research information to patients and practitioners as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders
Providing medical information; providing research information to patients and practitioners as to the results of clinical trials; providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders; providing research information to patients and practitioners as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders